Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

CPDM's Novel Method Development and Technology Evaluation

  • DNA and magnifying glass illustration

  • CPDM has a team of in vitro/in vivo technicians, bioinformaticians, and scientists offering a wide range of potential collaborations for specific novel method development around cancer modeling or model characterization, including novel assay development.

    CPDM welcomes partnering with academia and industry collaborators on method and technology evaluation; we can use cancer models and their associated rich clinical annotations to help validate the application of novel technologies prior to deployment.

    Please email us at models@dfci.harvard.edu to explore collaboration ideas.